Saniona is in the middle of a rights issue, where they can obtain SEK 64 million in net proceeds. We took the opportunity to conduct an interview with Saniona's CFO, Thomas Feldthus. In this interview, Thomas elaborates on: how they plan to use the net proceeds; the current status and development plan for the flagship project, Tesomet, in the two rare eating disorders, and lastly; why there is a good investment opportunity to take part in Saniona's rights issue.